NCT01880502View on ClinicalTrials.gov

Pharmacokinetic Study of Belviq in Adult Korean Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy
Interventions
DRUG

Belviq 10mg

Belviq 10mg single dose administration

DRUG

Belviq 20mg

Belviq 20mg single dose administration

DRUG

Placebo

Placebo single dose administration

Trial Locations (1)

110-744

Seoul National University Hospital, Jongno-gu

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT01880502 - Pharmacokinetic Study of Belviq in Adult Korean Volunteers | Biotech Hunter | Biotech Hunter